Clinical Trial: Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07432295) titled 'Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)' on Feb. 11.

Brief Summary: The goal of this clinical trial is to learn if givastomig in combination with standard therapy works to treat adults with cancer in the stomach and/or esophagus (GEA adenocarcinoma). It will also help the researchers to learn more about the safety of givastomig. The main questions it aims to answer are:

* Does the addition of givastomig to standard therapy increase the amount of time that participants survive without progression of their cancer?

* What toxicities do participants experi...